Exosomes based strategies for brain drug delivery

Fawad Ur Rehman, Yang Liu, Meng Zheng, Bingyang Shi*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

43 Citations (Scopus)

Abstract

Exosome application has emerged as a promising nanotechnology discipline for various diseases therapeutics and diagnoses. Owing to the natural properties of efficient drug delivery, higher biocompatibility, facile traversing of physiological barriers, and subtle side effects, exosomes shorten their way to clinical translation. Exosomes are nanoscale membrane-bound vesicles primarily involved in intercellular communication and exhibit natural blood-brain barrier (BBB) traversing ability, which enables their application as drug delivery vehicles for brain diseases treatment. Herein, we highlight recent exosome-based drug delivery endeavors for neurodegenerative diseases and brain cancer therapy, summarize the obstacles and future directions in clinical translation.
Original languageEnglish
Article number121949
Pages (from-to)1-18
Number of pages18
JournalBiomaterials
Volume293
Early online date8 Dec 2022
DOIs
Publication statusPublished - Feb 2023

Keywords

  • Exosomes
  • Drug delivery
  • Neurodegenerative diseases
  • Glioma
  • Blood-brain barrier

Fingerprint

Dive into the research topics of 'Exosomes based strategies for brain drug delivery'. Together they form a unique fingerprint.

Cite this